Planet to Launch 36 SuperDove Satellites with SpaceX
SAN FRANCISCO–(BUSINESS WIRE)–Planet Labs PBC (NYSE: PL), a leading provider of daily data and insights…
Month: December 2022
Astex Co-founder and CEO Harren Jhoti Awarded OBE in the King’s New Year Honours
Harren Jhoti OBE, PhD, FRS, FMedSci Astex Pharmaceuticals (UK), co-founder and CEO, Harren Jhoti OBE,…
CasaWire to Unveil Home + Décor Intelligence-Driven Platform Marketplace at CES ShowStoppers 2023
SEATTLE–(BUSINESS WIRE)–#amanza–The latest launch from Wire Holdings, Inc., CasaWire, the first highly curated home and…
Kovo HealthTech Provides Year-End Equity Incentive Plan Update
Vancouver, British Columbia–(Newsfile Corp. – December 30, 2022) – Kovo HealthTech Corporation (TSXV: KOVO) (the…
Cybeats Announces Two-Year Commercial Engagement with Global Leader in Digital Advertising Technology
Toronto, Ontario–(Newsfile Corp. – December 30, 2022) – Cybeats Technologies Corp. (CSE: CYBT) (“Cybeats” or the “Company”) is…
Alphoric Unveils 3-Pronged Authority Amplify Prospecting Approach to Generate and Close Leads Quicker
Washington, D.C.–(Newsfile Corp. – December 30, 2022) – Alphoric, a nationally ranked cold email outbound…
Momentus: Celebrating a Year of Progress with More to Come in 2023
SAN JOSE, Calif.–(BUSINESS WIRE)–Momentus Inc. (NASDAQ: MNTS) (“Momentus” or the “Company”), a U.S. commercial space…
CIM Real Estate Finance Trust, Inc. to Sell 185 Properties for $894 Million
Net proceeds to be deployed into senior secured loans PHOENIX–(BUSINESS WIRE)–CIM Real Estate Finance Trust,…
Sirona Biochem Announces 2022 Annual Meeting Results
VANCOUVER, British Columbia, Dec. 30, 2022 (GLOBE NEWSWIRE) — Sirona Biochem Corp. (TSX-V: SBM) (FSE:…
Valneva Reports Further Heterologous Booster Data for its inactivated COVID-19 vaccine
Saint-Herblain (France), December 30, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty…
Total number of shares and voting rights in Zealand Pharma at December 30, 2022
Company announcement – No. 58 / 2022 Total number of shares and voting rights in…
UPDATE – OncoC4 Announces First Patient Dosed in PRESERVE-004, a Phase 2 Clinical Trial of ONC-392 in Combination with KEYTRUDA® (Pembrolizumab) in Patients with Platinum-Resistant Ovarian Cancer
The Phase 2 multicenter, open-label combination trial builds upon the promising results of monotherapeutic activity…
CBB Bancorp, Inc. Announces Addition of Khoi D. Dang to Board of Directors, Retirement of Alvin D. Kang
LOS ANGELES–(BUSINESS WIRE)–CBB Bancorp, Inc. (the “Company”) (OTCQX: CBBI), the parent company of Commonwealth Business…
Cass Information Systems, Inc. Names Tony Urban as Executive Vice President and Transportation Information Services Business President.
ST. LOUIS–(BUSINESS WIRE)–Cass Information Systems, Inc. (Nasdaq: CASS), the leading provider of transportation, energy, telecom,…
Biora Therapeutics Announces Reverse Stock Split
SAN DIEGO, Dec. 30, 2022 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech…
Palisade Bio Announces $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under Nasdaq Rules
Carlsbad, CA, Dec. 30, 2022 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical…
OncoC4 Announces First Patient Dosed in PRESERVE-004, a Phase 2 Clinical Trial of ONC-392 in Combination with KEYTRUDA® (Pembrolizumab) in Patients with Platinum-Resistant Ovarian Cancer
The Phase 2 multicenter, open-label combination trial builds upon the promising results of monotherapeutic activity…
GT Biopharma, Inc. Announces $6.5 Million Registered Direct Offering Priced At Premium To Market
BRISBANE, CALIFORNIA, Dec. 30, 2022 (GLOBE NEWSWIRE) — GT Biopharma, Inc. (the “Company” or “GTB”)…
Connect Biopharma Provides Business and Clinical Development Program Update
Cash runway now expected to extend into at least 2025 as a result of revised…
BiondVax CEO Issues Letter to Shareholders
JERUSALEM, Dec. 30, 2022 (GLOBE NEWSWIRE) — via InvestorWire – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a…